Eledon Pharmaceuticals (ELDN) Capital Expenditures (2013 - 2016)
Eledon Pharmaceuticals posted quarterly Capital Expenditures of -$3000.0 for Q4 2016, down 101.39% year-on-year from $216000.0 in Q1 2016, and down 250.0% on a QoQ basis from $2000.0 in Q3 2016.
Eledon Pharmaceuticals (ELDN) has 4 years of Capital Expenditures data on file, last reported at -$3000.0 in Q4 2016.
- For the quarter ending Q4 2016, Capital Expenditures fell 101.39% year-over-year to -$3000.0; the trailing twelve-month figure through Dec 2016 stood at $9000.0 (down 98.41% YoY), and the FY2016 full-year result was $9000.0, down 98.41% from the prior year.
- Capital Expenditures for Q4 2016 stood at -$3000.0, down from $2000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $216000.0 in Q4 2015 and bottomed at -$7000.0 in Q2 2016.
- The 4-year median for Capital Expenditures is $9500.0 (2014), against an average of $50250.0.
- The widest annual swing landed in 2015, when Capital Expenditures soared 2350.0%; it then plunged 104.76% in 2016.
- A 4-year view of Capital Expenditures shows it stood at $4000.0 in 2013, then surged by 75.0% to $7000.0 in 2014, then jumped by 2985.71% to $216000.0 in 2015, then plunged by 101.39% to -$3000.0 in 2016.
- The last three Capital Expenditures figures came in at -$3000.0 (Q4 2016), $2000.0 (Q3 2016), and -$7000.0 (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Dec 31, 2015 | 216,000.00 |
| Dec 31, 2015 | 216,000.00 |
| Sep 30, 2015 | 157,000.00 |
| Sep 30, 2015 | 157,000.00 |
| Jun 30, 2015 | 147,000.00 |
| Jun 30, 2015 | 147,000.00 |
| Mar 31, 2015 | 45,000.00 |
| Mar 31, 2015 | 45,000.00 |
| Sep 30, 2014 | 7,000.00 |
| Sep 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Mar 31, 2014 | 12,000.00 |
| Mar 31, 2014 | 12,000.00 |
| Dec 31, 2013 | 4,000.00 |
| Dec 31, 2013 | 4,000.00 |